Coronavirus: Chinese COVID-19 vaccine enters third-stage human trial

COVID-19 vaccine: India could get access to AstraZeneca vaccine by January, says local manufacturer

Jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences, the vaccine was issued a clinical research permit from the National Medical Products Administration on June 19.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Visit the original:
ChinaPulse.com

Comments are closed.